Introduction: What is the PiggyBac Transposon System? The PiggyBac transposon system is a non-viral gene delivery tool that enables the insertion of specific genes into host genomes. Originally discov...
Latest breakthroughs in the treatment of breast cancerBy 2025, the domain of advanced breast cancer treatment is swiftly transforming, providing renewed optimism to patients globally. Recent advanceme...
CAR T Cell therapy for gastric cancer The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting introduced an important new cancer treatment: Satricabtagene autoleucel (satri-cel), a CAR T...
Professor Jiang Tao's Team from Beijing Tiantan Hospital Neurosurgery Leads the Establishment of China's First Advanced Innovative Treatment Clinic for Gliomas CureBreaking Through Treatment Dilemmas ...
Brain GliomaBrain glioma is one of the most common malignant tumors of the central nervous system. Despite numerous challenges in the treatment field, scientific advancements recently have brought new...
Introduction Chimeric Antigen Receptor (CAR) T-cell therapy has already transformed the landscape of cancer treatment. Now, the 4th generation CAR T-cell therapy, augmented with interleukin-15 (IL-15...
Cancer remains one of the most challenging diseases to treat, requiring innovative and effective therapies. One of the most promising advancements in cancer treatment is Chimeric Antigen Receptor (CA...
On November 8, 2024, the Food and Drug Administration sanctioned obecabtagene autoleucel (Aucatzyl, Autolus Inc.), a CD19-targeted genetically engineered autologous CAR T cell therapy, for people with...
IntroductionHematological malignancies, such as leukemias, lymphomas, and multiple myeloma, are a heterogeneous group of cancers that arise in the bone marrow and lymphatic system. Conventional trea...
CAR T Cell therapyChimeric Antigen Receptor (CAR) T-cell therapy is a revolutionary therapeutic strategy in hematologic malignancy treatment, recording high remission rates in therapy-refractory cas...